Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020

Clinical Breast Cancer(2023)10.1016/j.clbc.2023.05.001Source: DataRank Database

Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020 is a research paper published in Clinical Breast Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Topics (13)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yomaira Silva,Jun Lü ORCID,Zhengjia Chen ORCID,Vijayakrishna K. Gadi ORCID,Ryan H. Nguyen ORCID

Live enrichment

PubMed:37296063

Bristol-Myers Squibb Foundation

MeSH Terms

HumansBreast NeoplasmsResearch DesignUnited States Food and Drug AdministrationUnited StatesFemaleEthnicityHispanic or Latino

Keywords

PolicyHealth DisparitiesDrug ApprovalsRegistrational TrialsRegulatory Approvals